title: Therapeutic responses to different antimalarial drugs in vivax malaria.
abstract: The therapeutic responses to the eight most widely used antimalarial drugs were assessed in 207 adult patients with Plasmodium vivax malaria. This parasite does not cause marked sequestration, so parasite clearance can be used as a direct measure of antimalarial activity. The activities of these drugs in descending order were artesunate, artemether, chloroquine, mefloquine, quinine, halofantrine, primaquine, and pyrimethamine-sulfadoxine (PS). Therapeutic responses to PS were poor; parasitemias did not clear in 5 of the 12 PS-treated patients, whereas all the other patients made an initial recovery. Of 166 patients monitored for > or =28 days, 35% had reappearance of vivax malaria 11 to 65 days later and 7% developed falciparum malaria 5 to 21 days after the start of treatment. There were no significant differences in the times taken for vivax malaria reappearance among the different groups except for those given mefloquine and chloroquine, in which all vivax malaria reappearances developed >28 days after treatment, suggesting suppression of the first relapse by these slowly eliminated drugs. There was no evidence of chloroquine resistance. The antimalarial drugs vary considerably in their intrinsic activities and stage specificities of action.
authors.affiliation: Department of Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
authors.forename: S
authors.initials: S
authors.lastname: Pukrittayakamee
authors.forename: A
authors.initials: A
authors.lastname: Chantra
authors.forename: J A
authors.initials: JA
authors.lastname: Simpson
authors.forename: S
authors.initials: S
authors.lastname: Vanijanonta
authors.forename: R
authors.initials: R
authors.lastname: Clemens
authors.forename: S
authors.initials: S
authors.lastname: Looareesuwan
authors.forename: N J
authors.initials: NJ
authors.lastname: White
mesh_terms: D000328:Adult; D000818:Animals; D000962:Antimalarials / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D016780:Malaria, Vivax / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D010966:Plasmodium vivax / Q000187:drug effects; D016896:Treatment Outcome
chemical_list: D000962:Antimalarials